When you hear “spondylodiscitis in an IV drug user [IVDU],” what’s the first mental image? A catastrophically septic patient? A spine lighting up like a Christmas tree on MRI? A surgical course so fraught you need an emotional support coffee?
Well, brace yourself — because this study from three major spine centers across six years and 575 patients just threw a wrench into some long-held assumptions.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.

